Living Cell Technologies Ltd today announced its DiabeCell Type 1 diabetes treatment has been approved for a Phase I/IIA clinical trial in Russia designed according to FDA guidelines and monitored by a Boston-based Contract Research …

article continues at unknown brought to you by diabetes.medtrials.info and medtrials.info